PL1718679T3 - Estry kwasu hialuronowego z reiną, sposób otrzymywania oraz kompozycje je zawierające - Google Patents

Estry kwasu hialuronowego z reiną, sposób otrzymywania oraz kompozycje je zawierające

Info

Publication number
PL1718679T3
PL1718679T3 PL05708619T PL05708619T PL1718679T3 PL 1718679 T3 PL1718679 T3 PL 1718679T3 PL 05708619 T PL05708619 T PL 05708619T PL 05708619 T PL05708619 T PL 05708619T PL 1718679 T3 PL1718679 T3 PL 1718679T3
Authority
PL
Poland
Prior art keywords
hyaluronic acid
rhein
esters
compositions
preparation
Prior art date
Application number
PL05708619T
Other languages
English (en)
Inventor
Antonello Pietrangelo
Valter Travagli
Original Assignee
Laboratoire Medidom S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoire Medidom S A filed Critical Laboratoire Medidom S A
Publication of PL1718679T3 publication Critical patent/PL1718679T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/20—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Epidemiology (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Rheumatology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Pain & Pain Management (AREA)
  • Ophthalmology & Optometry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL05708619T 2004-02-26 2005-02-25 Estry kwasu hialuronowego z reiną, sposób otrzymywania oraz kompozycje je zawierające PL1718679T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT000347A ITMI20040347A1 (it) 2004-02-26 2004-02-26 Nuovo farmaco di associazione
EP05708619A EP1718679B1 (en) 2004-02-26 2005-02-25 Esters of hyaluronic acid with rhein, process for their preparation and compositions comprising the same
PCT/IB2005/000506 WO2005085293A1 (en) 2004-02-26 2005-02-25 Esters of hyaluronic acid with rhein, process for their preparation and compositions comprising the same

Publications (1)

Publication Number Publication Date
PL1718679T3 true PL1718679T3 (pl) 2008-01-31

Family

ID=34917538

Family Applications (1)

Application Number Title Priority Date Filing Date
PL05708619T PL1718679T3 (pl) 2004-02-26 2005-02-25 Estry kwasu hialuronowego z reiną, sposób otrzymywania oraz kompozycje je zawierające

Country Status (18)

Country Link
US (1) US7834173B2 (pl)
EP (1) EP1718679B1 (pl)
JP (2) JP4870068B2 (pl)
CN (1) CN100551932C (pl)
AT (1) ATE373681T1 (pl)
BR (1) BRPI0507622B8 (pl)
CA (1) CA2556942C (pl)
DE (1) DE602005002538T2 (pl)
ES (1) ES2293538T3 (pl)
HK (1) HK1099032A1 (pl)
IL (1) IL177072A (pl)
IT (1) ITMI20040347A1 (pl)
PL (1) PL1718679T3 (pl)
PT (1) PT1718679E (pl)
RU (1) RU2383554C2 (pl)
SI (1) SI1718679T1 (pl)
UA (1) UA91673C2 (pl)
WO (1) WO2005085293A1 (pl)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE20060049A1 (en) * 2006-01-25 2007-08-08 Eurand Pharmaceuticals Ltd A novel drug delivery system: use of hyaluronic acid as a carrier moleclue for different classes of therapeutic active agents
ITMI20062134A1 (it) * 2006-11-08 2008-05-09 Cbb Net S A Preparaziobne di esteri della diacereina con acido ialuronico e loro formulazioni per l'impiego farmaceutico
US20100136082A1 (en) 2006-12-22 2010-06-03 Laboratoire Medidom S.A. In situ system for intra-articular chondral and osseous tissue repair
ITMI20072237A1 (it) * 2007-11-27 2009-05-28 Sigea Srl Esteri misti butirrico-formico di polisaccaridi acidi, loro preparazione ed uso come dermocosmetici
WO2009133430A1 (en) * 2008-04-30 2009-11-05 Wockhardt Research Centre Topical compositions of rhein or diacerein
US8722644B2 (en) 2010-01-04 2014-05-13 Holy Stone Healthcare Co., Ltd. Mixture of hyaluronic acid for treating and preventing peptic ulcer and duodenal ulcer
JP2013533362A (ja) * 2010-07-29 2013-08-22 ユニバーシティ オブ ジュネーブ ヒアルロン酸の疎水性有機化合物とのエステル化用のプロセス
CN102603575B (zh) * 2012-01-04 2014-08-13 丛晓东 大精酸共晶物、其制备方法、纯化方法及其在制备治疗糖尿病并发症药物中的应用
GB2501943B (en) * 2012-05-10 2020-09-23 Zeiss Carl Meditec Ag Ophthalmic viscoelastic device
RU2534789C1 (ru) * 2013-06-19 2014-12-10 Сергей Алексеевич Успенский Твердофазный способ получения водорастворимого биоактивного нанокомпозита на основе модифицированной лимонной кислотой гиалуроновой кислоты и наночастиц золота
KR101486147B1 (ko) * 2013-07-09 2015-01-23 주식회사 엘지생활건강 Tslp 분비 저해능 및 이에 의한 알러지성 질환의 개선능을 가지는 조성물
MA41912A (fr) * 2015-04-07 2018-02-13 Hyalblue S R L Esters de glycosaminoglycane, procédés pour leur préparation et leur utilisation dans des formulations à usage ophtalmique
US20210260244A1 (en) * 2018-06-29 2021-08-26 Merz Pharma Gmbh & Co. Kgaa Fatty acid-grafted hyaluronic acid, dermal filler formulations comprising same, process for preparation and use thereof
CN109833292A (zh) * 2019-02-23 2019-06-04 河南省人民医院 一种双醋瑞因滴眼液及其用途
CN112138169A (zh) * 2020-09-14 2020-12-29 广东药科大学 天然多糖在增加难溶性药物溶解度中的应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4788187A (en) * 1983-04-29 1988-11-29 Rorer Pharmaceutical Corporation Benzocyclobutene aminoalkylene ethers and thioethers, pharmaceutical composition and use
NZ245989A (en) * 1992-02-28 1995-02-24 Lilly Industries Ltd Anthraquinone derivatives and pharmaceutical compositions
US5573934A (en) * 1992-04-20 1996-11-12 Board Of Regents, The University Of Texas System Gels for encapsulation of biological materials
ZA936692B (en) * 1992-09-12 1994-04-29 Dott Ltd Comp Physiologically active peptide composition
CA2094203A1 (en) * 1993-04-16 1994-10-17 Derek A. Willoughby Inhibition of angiogenesis
US5612321A (en) * 1995-06-22 1997-03-18 Hercules Incorporated Antioxidant grafted polysaccharides
FR2751615B1 (fr) * 1996-07-23 1998-09-18 Otor Sa Plateau et flan en matiere en feuille de carton
JP3322203B2 (ja) * 1997-01-31 2002-09-09 田辺製薬株式会社 医薬組成物
AU752280C (en) * 1998-05-20 2005-03-03 Chugai Seiyaku Kabushiki Kaisha Conjugate of therapeutic agent for joint disease and hyaluronic acid.
ITMI20022745A1 (it) * 2002-12-23 2004-06-24 Coimex Scrl United Companies Esteri misti dell'acido ialuronico ad attivita' citostatica e prodifferenziante e procedimento per la loro produzione.

Also Published As

Publication number Publication date
ES2293538T3 (es) 2008-03-16
US20070203094A1 (en) 2007-08-30
HK1099032A1 (en) 2007-08-03
JP2011252153A (ja) 2011-12-15
CA2556942C (en) 2012-05-29
EP1718679B1 (en) 2007-09-19
CN100551932C (zh) 2009-10-21
EP1718679A1 (en) 2006-11-08
JP2007524753A (ja) 2007-08-30
CA2556942A1 (en) 2005-09-15
US7834173B2 (en) 2010-11-16
CN1914228A (zh) 2007-02-14
RU2006134015A (ru) 2008-04-10
BRPI0507622B8 (pt) 2021-05-25
ATE373681T1 (de) 2007-10-15
JP4870068B2 (ja) 2012-02-08
PT1718679E (pt) 2007-11-27
SI1718679T1 (sl) 2008-02-29
BRPI0507622A (pt) 2007-07-03
ITMI20040347A1 (it) 2004-05-26
UA91673C2 (ru) 2010-08-25
DE602005002538D1 (de) 2007-10-31
IL177072A0 (en) 2006-12-10
RU2383554C2 (ru) 2010-03-10
WO2005085293A1 (en) 2005-09-15
DE602005002538T2 (de) 2008-06-19
IL177072A (en) 2011-02-28
BRPI0507622B1 (pt) 2018-07-17

Similar Documents

Publication Publication Date Title
HK1099032A1 (en) Esters of hyaluronic acid with rhein, process for their preparation and compositions comprising the same
BR112012006681A2 (pt) método para produzir uma composição de ésteres de ácidos graxos, composição de ésteres de ácidos graxos método para produzir uma composição de ésteres graxos e composição de biocombustivel
EP4338805A3 (en) Methods of reducing the risk of a cardiovascular event in a subject on statin therapy
PH12016500216B1 (en) Stable pharmaceutical composition and methods of using same
NZ597193A (en) Compositions and methods for lowering triglycerides without raising ldl-c levels in a subject on concomitant statin therapy
EP2588518A4 (en) Cellulosic and cellulosic esters / elastomers compositions and method of preparation therefor
EP2679687A3 (en) Fatty acid blends and uses therefor
NZ618734A (en) Polyunsaturated fatty acids for the treatment of diseases related to cardiovascular, metabolic and inflammatory disease areas
BRPI1014472A8 (pt) Método para produzir um derivado de ácido graxo, microrganismo engenheirado geneticamente, derivado de ácido graxo e composição de biocombustível
NZ708558A (en) Preparation of poly alpha-1,3-glucan esters and films therefrom
EP2194119A3 (en) Production of fatty acids and derivatives thereof
EP2840131A3 (en) Production of fatty acids and derivatives thereof
WO2005103253A8 (en) Synthesis of long-chain polyunsaturated fatty acids by recombinant cells
WO2008063300A3 (en) Boronic acids and esters as inhibitors of fatty acid amide hydrolase
UA102574C2 (ru) 1-фенил-2-пиридинилалкил-спиртовые производные как ингибиторы фосфодиэстеразы
WO2009150022A3 (de) Verfahren zur herstellung von sphingolipiden durch enzymatische n-acylierung von lysosphingolipiden unter verwendung einer pilz-lipase und eines fettsäurealkylesters
SG10201805198TA (en) 18f - fluciclovine compositions in citrate buffers
TW200942513A (en) Process for the preparation of fatty acid alkyl esters
WO2009095197A3 (de) Zusammensetzungen enthaltend phosphorsäureester und hydrophob modifizierte, vernetzte, anionische polymere
WO2011051968A3 (en) Pharmaceutical compositions of lanthanum carbonate and process for the preparation thereof
WO2009150023A3 (de) Verfähren zur herstellung von sphingolipiden durch enzymatische n-acylierung von lysosphingolipiden unter verwendung einer lipase und eines fettsäureglycerinesters
MX2010005702A (es) Esteres butirico-formico mixtos de polisacaridos acidos, y su preparacion y uso como cosmeticos para la piel.
WO2010108060A8 (en) Fatty acid monoglyceride compositions
WO2011103193A3 (en) COPOLYESTERS HAVING REPEAT UNITS DERIVED FROM ω-HYDROXY FATTY ACIDS
MY182542A (en) Methods of refining and producing dibasic esters and acids from natural oil feedstocks